+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pompe Disease Market Research Report by Therapy Type (Enzyme and Substrate), Molecule Type, Dosage Form, Route of Administration, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 255 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968988
UP TO OFF until Dec 31st 2022
The Global Pompe Disease Market size was estimated at USD 1,358.53 million in 2021, USD 1,430.97 million in 2022, and is projected to grow at a CAGR 5.50% to reach USD 1,874.20 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pompe Disease to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Therapy Type, the market was studied across Enzyme and Substrate.
  • Based on Molecule Type, the market was studied across Biologics and Small Molecules.
  • Based on Dosage Form, the market was studied across Liquid and Solid.
  • Based on Route of Administration, the market was studied across Oral and Parental.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pompe Disease market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pompe Disease Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pompe Disease Market, including Amicus Therapeutics, Inc., Astellas Pharma Inc, AVROBIO, Inc., B Braun Melsungen AG, Becton, Dickinson & Company, BioMarin Pharmaceutical Inc, CENTOGENE AG, CENTOGENE N.V., EpiVax, Inc., Flowserve Corporation, GlaxoSmithKline PLC, Koninklijke Philips NV, Medline Industries Inc, Merck KGaA, Novartis AG, Oxyrane UK Ltd., Pfizer Inc, Pharming Group NV, Sangamo BioSciences, Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pompe Disease Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pompe Disease Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pompe Disease Market?
4. What is the competitive strategic window for opportunities in the Global Pompe Disease Market?
5. What are the technology trends and regulatory frameworks in the Global Pompe Disease Market?
6. What is the market share of the leading vendors in the Global Pompe Disease Market?
7. What modes and strategic moves are considered suitable for entering the Global Pompe Disease Market?
Frequently Asked Questions about the Global Pompe Disease Market

What is the estimated value of the Global Pompe Disease Market?

The Global Pompe Disease Market was estimated to be valued at $1358.53 Million in 2021.

What is the growth rate of the Global Pompe Disease Market?

The growth rate of the Global Pompe Disease Market is 5.5%, with an estimated value of $1874.2 Million by 2027.

What is the forecasted size of the Global Pompe Disease Market?

The Global Pompe Disease Market is estimated to be worth $1874.2 Million by 2027.

Who are the key companies in the Global Pompe Disease Market?

Key companies in the Global Pompe Disease Market include Amicus Therapeutics, Inc., Astellas Pharma Inc, AVROBIO, Inc., B Braun Melsungen AG, Becton, Dickinson & Company, BioMarin Pharmaceutical Inc, CENTOGENE AG, CENTOGENE N.V. and Flowserve Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of pompe disease
5.1.1.2. Uptake of long term therapies
5.1.1.3. Increasing developments in the gene therapy and enzyme replacement therapies
5.1.2. Restraints
5.1.2.1. High treatment costs associated with the treatment of pompe diseases
5.1.3. Opportunities
5.1.3.1. Advancement in the diagnosis and treatment
5.1.3.2. Increasing investment in the research and development
5.1.3.3. Government initiatives for the development and manufacture of innovative products
5.1.4. Challenges
5.1.4.1. Lack of awareness about the treatment
5.2. Cumulative Impact of COVID-19
6. Pompe Disease Market, by Therapy Type
6.1. Introduction
6.2. Enzyme
6.3. Substrate
7. Pompe Disease Market, by Molecule Type
7.1. Introduction
7.2. Biologics
7.3. Small Molecules
8. Pompe Disease Market, by Dosage Form
8.1. Introduction
8.2. Liquid
8.3. Solid
9. Pompe Disease Market, by Route of Administration
9.1. Introduction
9.2. Oral
9.3. Parental
10. Americas Pompe Disease Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pompe Disease Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Pompe Disease Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Amicus Therapeutics, Inc.
14.2. Astellas Pharma Inc
14.3. AVROBIO, Inc.
14.4. B Braun Melsungen AG
14.5. Becton, Dickinson & Company
14.6. BioMarin Pharmaceutical Inc
14.7. CENTOGENE AG
14.8. CENTOGENE N.V.
14.9. EpiVax, Inc.
14.10. Flowserve Corporation
14.11. GlaxoSmithKline PLC
14.12. Koninklijke Philips NV
14.13. Medline Industries Inc
14.14. Merck KGaA
14.15. Novartis AG
14.16. Oxyrane UK Ltd.
14.17. Pfizer Inc
14.18. Pharming Group NV
14.19. Sangamo BioSciences, Inc.
14.20. Sanofi S.A.
14.21. Takeda Pharmaceutical Company Limited
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL POMPE DISEASE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL POMPE DISEASE MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL POMPE DISEASE MARKET DYNAMICS
FIGURE 8. GLOBAL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2027
FIGURE 11. GLOBAL POMPE DISEASE MARKET SIZE, BY ENZYME, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL POMPE DISEASE MARKET SIZE, BY ENZYME, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL POMPE DISEASE MARKET SIZE, BY SUBSTRATE, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2021 VS 2027 (%)
FIGURE 16. GLOBAL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2027
FIGURE 18. GLOBAL POMPE DISEASE MARKET SIZE, BY BIOLOGICS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (%)
FIGURE 23. GLOBAL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2027
FIGURE 25. GLOBAL POMPE DISEASE MARKET SIZE, BY LIQUID, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL POMPE DISEASE MARKET SIZE, BY LIQUID, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL POMPE DISEASE MARKET SIZE, BY SOLID, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL POMPE DISEASE MARKET SIZE, BY SOLID, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 30. GLOBAL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 32. GLOBAL POMPE DISEASE MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL POMPE DISEASE MARKET SIZE, BY ORAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL POMPE DISEASE MARKET SIZE, BY PARENTAL, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL POMPE DISEASE MARKET SIZE, BY PARENTAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. AMERICAS POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 38. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2027
FIGURE 40. ARGENTINA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. BRAZIL POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. CANADA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. MEXICO POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 46. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2027
FIGURE 48. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 50. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2027
FIGURE 52. AUSTRALIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. CHINA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. INDIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. INDONESIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. JAPAN POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. MALAYSIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. PHILIPPINES POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SINGAPORE POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SOUTH KOREA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. TAIWAN POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. THAILAND POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2027
FIGURE 67. FRANCE POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. GERMANY POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. ITALY POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. NETHERLANDS POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. QATAR POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. RUSSIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. SAUDI ARABIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SOUTH AFRICA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. SPAIN POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. UNITED KINGDOM POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. GLOBAL POMPE DISEASE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 79. GLOBAL POMPE DISEASE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL POMPE DISEASE MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL POMPE DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL POMPE DISEASE MARKET SIZE, BY ENZYME, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS POMPE DISEASE MARKET SIZE, BY ENZYME, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES POMPE DISEASE MARKET SIZE, BY ENZYME, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY ENZYME, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY ENZYME, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 28. GLOBAL POMPE DISEASE MARKET SIZE, BY LIQUID, BY REGION, 2019-2027 (USD MILLION)
TABLE 29. AMERICAS POMPE DISEASE MARKET SIZE, BY LIQUID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES POMPE DISEASE MARKET SIZE, BY LIQUID, BY STATE, 2019-2027 (USD MILLION)
TABLE 31. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY LIQUID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY LIQUID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. GLOBAL POMPE DISEASE MARKET SIZE, BY SOLID, BY REGION, 2019-2027 (USD MILLION)
TABLE 34. AMERICAS POMPE DISEASE MARKET SIZE, BY SOLID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES POMPE DISEASE MARKET SIZE, BY SOLID, BY STATE, 2019-2027 (USD MILLION)
TABLE 36. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY SOLID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY SOLID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 39. GLOBAL POMPE DISEASE MARKET SIZE, BY ORAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 40. AMERICAS POMPE DISEASE MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. UNITED STATES POMPE DISEASE MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 42. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. GLOBAL POMPE DISEASE MARKET SIZE, BY PARENTAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 45. AMERICAS POMPE DISEASE MARKET SIZE, BY PARENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES POMPE DISEASE MARKET SIZE, BY PARENTAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY PARENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY PARENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 55. ARGENTINA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. ARGENTINA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 57. ARGENTINA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 58. ARGENTINA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 59. ARGENTINA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 60. BRAZIL POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. BRAZIL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 62. BRAZIL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 63. BRAZIL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 64. BRAZIL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 65. CANADA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. CANADA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 67. CANADA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 68. CANADA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 69. CANADA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 70. MEXICO POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. MEXICO POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 72. MEXICO POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 73. MEXICO POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 74. MEXICO POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 77. UNITED STATES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 79. UNITED STATES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 85. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 87. AUSTRALIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. AUSTRALIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 89. AUSTRALIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 90. AUSTRALIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 91. AUSTRALIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 92. CHINA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. CHINA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 94. CHINA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 95. CHINA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 96. CHINA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 97. INDIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. INDIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 99. INDIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 100. INDIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 101. INDIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 102. INDONESIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. INDONESIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 104. INDONESIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 105. INDONESIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 106. INDONESIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 107. JAPAN POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. JAPAN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 109. JAPAN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 110. JAPAN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 111. JAPAN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 112. MALAYSIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. MALAYSIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 114. MALAYSIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 115. MALAYSIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 116. MALAYSIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 117. PHILIPPINES POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. PHILIPPINES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 119. PHILIPPINES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 120. PHILIPPINES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 121. PHILIPPINES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 122. SINGAPORE POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. SINGAPORE POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 124. SINGAPORE POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 125. SINGAPORE POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 126. SINGAPORE POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 127. SOUTH KOREA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 129. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 130. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 131. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 132. TAIWAN POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. TAIWAN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 134. TAIWAN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 135. TAIWAN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 136. TAIWAN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 137. THAILAND POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. THAILAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 139. THAILAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 140. THAILAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 141. THAILAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 148. FRANCE POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. FRANCE POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 150. FRANCE POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 151. FRANCE POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 152. FRANCE POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 153. GERMANY POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. GERMANY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 155. GERMANY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 156. GERMANY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 157. GERMANY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 158. ITALY POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 159. ITALY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 160. ITALY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 161. ITALY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 162. ITALY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 163. NETHERLANDS POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 164. NETHERLANDS POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 165. NETHERLANDS POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 166. NETHERLANDS POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 167. NETHERLANDS POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 168. QATAR POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 169. QATAR POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 170. QATAR POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 171. QATAR POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 172. QATAR POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 173. RUSSIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. RUSSIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 175. RUSSIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 176. RUSSIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 177. RUSSIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 178. SAUDI ARABIA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 180. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 181. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 182. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 183. SOUTH AFRICA POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 185. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 186. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 187. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 188. SPAIN POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 189. SPAIN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 190. SPAIN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 191. SPAIN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 192. SPAIN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 198. UNITED KINGDOM POMPE DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 199. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 200. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2019-2027 (USD MILLION)
TABLE 201. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 202. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 203. GLOBAL POMPE DISEASE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 204. GLOBAL POMPE DISEASE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 205. GLOBAL POMPE DISEASE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 206. GLOBAL POMPE DISEASE MARKET RANKING
TABLE 207. GLOBAL POMPE DISEASE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 208. GLOBAL POMPE DISEASE MARKET MERGER & ACQUISITION
TABLE 209. GLOBAL POMPE DISEASE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 210. GLOBAL POMPE DISEASE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 211. GLOBAL POMPE DISEASE MARKET INVESTMENT & FUNDING
TABLE 212. GLOBAL POMPE DISEASE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 213. GLOBAL POMPE DISEASE MARKET: LICENSE & PRICING

Companies Mentioned

  • Amicus Therapeutics, Inc.
  • Astellas Pharma Inc
  • AVROBIO, Inc.
  • B Braun Melsungen AG
  • Becton, Dickinson & Company
  • BioMarin Pharmaceutical Inc
  • CENTOGENE AG
  • CENTOGENE N.V.
  • EpiVax, Inc.
  • Flowserve Corporation
  • GlaxoSmithKline PLC
  • Koninklijke Philips NV
  • Medline Industries Inc
  • Merck KGaA
  • Novartis AG
  • Oxyrane UK Ltd.
  • Pfizer Inc
  • Pharming Group NV
  • Sangamo BioSciences, Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...